Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials

Post time 5 day(s) ago

journal：Circulation

Authors：William F. McIntyre; Alexander P. Benz; Nina Becher; Jeffrey S. Healey; Christopher B. Granger; Lena Rivard; A. John Camm; Andreas Goette; Antonia Zapf; Marco Alings; Stuart J. Connolly; Paulus Kirchhof; Renato D. Lopes

Published date：2024-3-26

DOI：10.1161/circulationaha.123.067512

PDF link：https://www.ahajournals.org/doi/ ... ATIONAHA.123.067512

Article link：http://dx.doi.org/10.1161/circulationaha.123.067512

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 5 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AHA] Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials